Intersect Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Intersect Capital's ELV Position: Q2 2022 in Review
Intersect Capital increased its Elevance Health (ELV) stake by 21% in Q2 2022, buying an estimated $160K and bringing the position to 1,889 shares worth $912K. The position accounts for 0.28% of the portfolio, ranked #84.
Intersect Capital first reported a position in ELV in Q4 2014 and has held it in 5 quarters since. 1,441 funds tracked by Wall St. Rank hold ELV as of Q2 2022.
- Intersect Capital held 1,889 shares of Elevance Health worth $912K as of Q2 2022.
- Intersect Capital bought 323 Elevance Health shares in Q2 2022, an estimated $160K.
- Elevance Health made up 0.28% of Intersect Capital's portfolio in Q2 2022, its #84 holding.
- Intersect Capital first reported a position in Elevance Health in Q4 2014 and has held it in 5 quarters since.
- 1,441 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.
Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.